Table of Contents Table of Contents
Previous Page  95 / 152 Next Page
Information
Show Menu
Previous Page 95 / 152 Next Page
Page Background

Abstracts / Journal of Clinical Virology 82S (2016) S1–S142

S91

ues. Differences between the groups were analyzed for statistical

significance using

T

-test.

A significantly higher expression of mRNA levels of XRCC1, DNA

PkI and FasR was detected in HIV infected individuals than in HD

(XRCC1: CT naïve = 13.7; CT INI-cART = 15.2 and CT HD =

5.5;

p

< 0.05. DNA Pk1: CT naïve = 9.7; CT INI-cART = 14.3 and CT

HD =

2.2;

p

< 0.05; FasR: CT naïve = 14.5; CT INI-cART = 12.3

and CT HD =

0.4;

p

< 0.05).

No significant differences in expression of DNA Pk II, Lig III

and Parp-1 mRNA levels between treatment naïve patients, ART

containing INI treated patients and healthy donors were detected

(DNA Pk II: CT naïve = 6.7; CT INI-cART = 5.3; CT HD = 11.14;

Lig III : CT naïve = 8.1; CT INI-cART = 8.44; CT HD = 13.08;

Parp-1: CT naïve = 4.6; CT INI-cART = 5.6; CT HD 8.1;

p

> 0.05).

The expression levels of some DNA damage genes (XRCC1, FasR

and DNA PKI) are higher in HIV+ patients than in healthy donors. No

difference of DNA PK II, Parp-1 and Lig III alpha mRNA expression

levels were observed between HIV+ patients and HD. Interest-

ingly, no significant difference between naïve and INI-cART treated

patients was observed. This data suggests that a cellular damage

persist despite suppression of viral replication.

http://dx.doi.org/10.1016/j.jcv.2016.08.180

Abstract no: 305

Presentation at ESCV 2016: Poster 141

Molecular studies on HSV: Replication rate,

infection capacity and progeny

A. Azevedo

, A. Nunes, C. Roque, I. Costa,

J.P. Gomes, S. Lopo

Department of Infectious Diseases, National Institute

of Health-Lisbon, Portugal

Introduction:

In the last years genital herpes has emerged as

one of the most prevalent sexually transmitted infections. Herpes

simplex virus (HSV) is the most common cause of genital ulcer dis-

ease, with infections caused by both sub-types HSV-1 and HSV-2.

A better understanding of the virus replication cycle is relevant to

the pathogenesis of human diseases and is essential for the devel-

opment of antiviral chemotherapy.

Objectives:

We aimed to shed some light on the HSV-1 andHSV-

2 infectious cycle, namely their capacity of infection, replication

rate and progeny, in three distinct cell lines (Vero, Vero E6 and

HeLa229). We also aimed to evaluate whether the concentration of

virus has any influence on the degree of the infection.

Methodology:

Preliminary assays were performed in order

to understand which cellular concentration, viral load, nutrients’

availability and inoculation

modus operandi

(centrifugation

versus

agitation) best mimic the HSV infection. Confluent cell monolayers

were infected with two HSV-2 and two HSV-1 at MOIs of 1:10, 1:1,

10:1 and 100:1. Inoculations were performed in parallel in two 24-

well plates, one for quantitative real-time PCR (kPCR) and one for

immunofluorescence assays, whichwere incubated for 30 h at 37

C

and 5% CO

2

. At different times-points of infection (6, 12, 18, 24 and

30 h p.i.), the wells were scratched for kPCR and the slides were

stained with monoclonal antibodies. For kPCR assays, appropriate

standard curves were generated by serial diluting plasmids cloned

with HSV-1 and HSV-2 single copy genes.

Results and conclusions:

Preliminary assays showed that,

regardless of the viral load, it takes approximately 23 h for the virus

to complete the infectious cycle taking into account that no replica-

tion is observed after this time point. Considering the comparison

between the two inoculation procedures (centrifugation

versus

agi-

tation), we only observed relevant differences for lower viral loads,

with centrifugation yielding more viral progeny. More specific data

regarding both the HSV-1 and HSV-2 replication capacity for differ-

ent MOIs are currently under evaluation.

http://dx.doi.org/10.1016/j.jcv.2016.08.181

Abstract no: 318

Presentation at ESCV 2016: Poster 142

Genetic diversity and drug resistance profiles of

human immunodeficiency virus type 1 (HIV-1)

strains infecting pregnant women in the

Greater Lisbon

C. Simões

1 ,

, E. Pádua

2

, A. Mendes

1

, A. Esteves

1

,

R. Parreira

1 , J. P

iedade

1

1

GHTM, Grupo de Virologia, Unidade de

Microbiologia Médica, Instituto de Higiene e

Medicina Tropical, Universidade Nova de Lisboa,

Lisbon, Portugal

2

Laboratório Nacional de Referência IST – VIH e

Hepatites B e C, Departamento de Doenc¸ as

Infecciosas, Instituto Nacional de Saúde Dr. Ricardo

Jorge, Lisbon, Portugal

According to the UNAIDS (The Joint United Nations Programme

on HIV/AIDS), human immunodeficiency virus (HIV) infected 36.9

million people at the end of 2014, of whom 2.6 million were chil-

dren under 15 years of age. Vertical transmission is the main cause

of infection in children and while the associated risk has decreased

dramatically with the introduction of highly active antiretroviral

therapy (HAART), this transmission continues to occur. Although

it has been the subject of significant progress in recent years,

the access of pregnant women to therapy still remains difficult

in certain regions. Moreover, in some cases, the presence of viral

mutations associated with resistance is responsible for the failure

of the implemented prophylactic regimens and may consequently

lead to transmission of resistant viruses to newborns.

This study included a group of 34 multiparous women infected

with HIV-1, fromwhom a sample of peripheral blood was collected

within two days after delivery, between 1999 and 2008. The great

majority of the women had followed therapeutic regimens for pre-

vention of vertical transmission of HIV-1 during pregnancy. The

proviral DNA of 70 samples analyzed was extracted and purified

from peripheral blood mononuclear cells, being the amplification

of the protease coding region carried out by double nested PCR.

After nucleotide sequencing, the genetic characterization of the

viral strains bymanual phylogenetic analysis was performed, along

with the characterization of resistance-associated mutations, as

well as other genetic polymorphisms, using the HIVdb program

(available at

http://hivdb.stanford.edu/

).

The study revealed a high genetic diversity of HIV-1 within

this population, with predominance of G (47.8%), C (14.9%), and B

(11.9%) subtypes, and also a high prevalence of unique recombinant

forms (16.4%). Non-B subtypes were responsible for the infection

in all women of African origin, and the B subtype was only found

in Portuguese women. Additionally, African women were the only

infectedwith subtype C. Considering themutations associatedwith

resistance to protease inhibitors (PIs), two major mutations (D30N

and M46I) and seven minor mutations (L10I, L10V, L33F, G48E,

A71T, A71V, and T74S) were identified, in 19 of the sequences

studied. Of these, 16 were classified as non-B subtypes, but no

statistically significant association was found. Furthermore, most

of these mutations were detected in women whose prophylac-

tic regimens included PIs, which may have led to their selection.

The remaining genetic polymorphisms, not associated with anti-